AD Clinical Study
You could be part of research for an investigational oral drug that may reduce symptoms of atopic dermatitis (AD), commonly called eczema. The BROADEN 2 Trial is looking for people who:
- Are age 18–75
- Have had eczema for at least 3 years
- Have tried certain medications but still experience pain, redness, and flares that impact daily life
Other requirements apply. Contact us to learn more.
